SCIENTIFIC HORIZONS CONSULTING LLC
Inhalation device with novel atomizer technology for dose-controlled pulmonary delivery of anti-inflammatory medicines to deep lung
- Sector
- Medtech
- Total capital
- $1M
- Federal grants
- $1M
- 4 awards · 2024–2026
- Rank in peer group#448 of 477
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 11 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Water Inhalable Nicotine (WIN) as An Innovative Orally Inhaled Nicotine Replacement Therapy (NRT) for Smoking Cessation$399K
- Federal grantHealth and Human S · Phase I · A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)$55K
- Federal grantHealth and Human S · Phase I · A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)$275K
- Federal grantHealth and Human S · Phase I · Pulmonary Delivery of Antibiotics Co-crystalized with Cyclodextrin-based Metal Organic Frameworks to Treat Non-Tuberculous Mycobacterial (NTM) Infections$299K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 11- PendingSystems And Methods For Estimating Aerosolization EmissionUSPTOApplication 19113241
- PendingCo-crystallization Of Actives With Saccharide-based Molecular FrameworksUSPTOApplication PCTUS2024050387
- PendingHydrogel Oral Delivery Systems And MethodsUSPTOApplication PCTUS2024049456
Show all 11 patent records
- Systems And Methods For Estimating Aerosolization EmissionApr 2, 2026 · Application 19113241Pending
- Co-crystallization Of Actives With Saccharide-based Molecular FrameworksApplication PCTUS2024050387Pending
- Hydrogel Oral Delivery Systems And MethodsApplication PCTUS2024049456Pending
- Nicotine Complexes And Methods Of Use In The Adjustment Of Nicotine Harshness And Release KineticsApplication PCTUS2024048667Pending
- Co-crystallization Of Actives With Saccharide-based Molecular FrameworksApplication 63543472Pending
- Hydrogel Oral Delivery Systems And MethodsApplication 63542267Pending
- Nicotine Complexes And Methods Of Use In The Adjustment Of Nicotine Harshness And Release KineticsApplication 63541709Pending
- Systems And Methods For Estimating Aerosolization EmissionApplication PCTUS2023074889Pending
- Systems And Methods For Estimating A Consumable Emission And ConsumptionApplication 63409324Pending
- Co-crystallization Of Actives With Saccharide-based Molecular FrameworksApplication 19526130Pending
- Hydrogel Oral Delivery Systems And MethodsApplication 19525149Pending
Related companies, and why
- Bone Foam, Inc.Similar federal contract value in Medtech · null in contracts
- KOBUK TECHNOLOGIES LLCSimilar federal contract value in Medtech · null in contracts
- PARTURA Medical, Inc.Similar federal contract value in Medtech · null in contracts
- MojixSimilar federal contract value in Medtech · null in contracts
- Love Lifesciences LLCSimilar federal contract value in Medtech · null in contracts
- Assurtek Surgical, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .